Oncare's ₹27 Cr bet on distributed oncology care in India's Tier-2 cities

Oncare closed a Series A round of ₹27 Cr (approximately $3M) in February 2026, led by Sky Impact Capital and joined by Huddle Ventures, Lotus Herbal Group, SteerX, and Tremis Capital. The startup operates a distributed oncology care model—partnering with accredited hospitals rather than building standalone facilities—to integrate medical, surgical, and radiation oncology services under a single platform. Founded in 2023 by Amar Sneh and Deepak Kumar, Oncare currently operates multiple centres across Delhi NCR and plans to expand into new metro cities and Tier-2 and Tier-3 markets using the fresh capital. The company also intends to invest in technology to improve clinical operations, care coordination, and patient experience.

The round arrives amid accelerating investor interest in India’s oncology sector, with the market projected to reach ₹43,000 Cr by FY28 at around 14% CAGR. Broader Indian healthtech saw nearly $700 Mn in funding in 2025, with investor focus spanning diagnostics, AI-led treatment support, and full-stack care platforms. Concurrent bets on specialized oncology tech include 4baseCare’s ₹90 Cr raise for AI-driven genomic and clinical data analysis, and RISA Labs’ $11.1 Mn Series A for healthcare AI. The wider healthtech sector is expected to grow at 39% CAGR between 2025 and 2030 to exceed $37 Bn, signaling sustained capital allocation to vertical health models.

The open question is whether Oncare’s platform-based partnership model can achieve unit economics that justify expansion into Tier-2 and Tier-3 markets, where hospital infrastructure and patient willingness to coordinate care across facilities may differ materially from metro conditions. Worth watching whether the company’s technology investments in care coordination and patient experience become the primary lever for retention and referral in less dense markets. The bet appears to rest on standardized, transparent cancer care protocols gaining adoption beyond Delhi NCR—a thesis that will hinge on execution across heterogeneous hospital partners and patient populations.